Potential Alzheimer’s therapy

More from this show

The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer’s disease. The five-year grant will fund a national clinical trial to determine whether alloprognanalone, or allo, is an effective treatment for those with early-stage Alzheimer’s who have a genetic risk for the disease. We hear more from Roberta Diaz Brinton, director of the Center for Innovation in Brain Science.

Roberta Diaz Brinton, director of the Center for Innovation in Brain Science

A graphic reading: Protect my public media

Protect My Public Media: Add your voice today

Diners eat outside on an episode of Check, Please! Arizona

Be a guest on “Check, Please! Arizona”

A television with logos from Arizona PBS and Amazon Prime on the screen

Arizona PBS is now free to stream for Prime Video viewers in the U.S.

A graphic for the Arizona PBS news show,
aired May 10

‘Horizonte’ on creating an inclusive medical system

Subscribe to Arizona PBS Newsletters

STAY in touch
with azpbs.org!

Subscribe to Arizona PBS Newsletters: